Pratik S Multani - Net Worth and Insider Trading
Pratik S Multani Net Worth
The estimated net worth of Pratik S Multani is at least $537,955 dollars as of 2024-05-15. Pratik S Multani is the Director of Erasca Inc and owns about 172,866 shares of Erasca Inc (ERAS) stock worth over $321,531. Pratik S Multani is also the Chief Medical Officer of ORIC Pharmaceuticals Inc and owns about 23,809 shares of ORIC Pharmaceuticals Inc (ORIC) stock worth over $216,424. Details can be seen in Pratik S Multani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pratik S Multani has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).
Transaction Summary of Pratik S Multani
Pratik S Multani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pratik S Multani owns 5 companies in total, including Chimerix Inc (CMRX) , ORIC Pharmaceuticals Inc (ORIC) , and Ignyta Inc (RXDX) among others .
Click here to see the complete history of Pratik S Multani’s form 4 insider trades.
Insider Ownership Summary of Pratik S Multani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2020-02-21 | director |
| ORIC | ORIC Pharmaceuticals Inc | 2023-12-15 | Chief Business Officer |
| RXDX | Ignyta Inc | 2018-02-08 | Chief Medical Officer |
 | | 2013-09-30 | Chief Medical Officer |
| | 2021-07-20 | director |
Pratik S Multani Latest Holdings Summary
Pratik S Multani currently owns a total of 2 stocks. Among these stocks, Pratik S Multani owns 172,866 shares of Erasca Inc (ERAS) as of July 20, 2021, with a value of $321,531 and a weighting of 59.77%. Pratik S Multani also owns 23,809 shares of ORIC Pharmaceuticals Inc (ORIC) as of December 15, 2023, with a value of $216,424 and a weighting of 40.23%.
Latest Holdings of Pratik S Multani
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ERAS | Erasca Inc | 2021-07-20 | 172,866 | 1.86 | 321,531 |
| ORIC | ORIC Pharmaceuticals Inc | 2023-12-15 | 23,809 | 9.09 | 216,424 |
Holding Weightings of Pratik S Multani
Pratik S Multani Form 4 Trading Tracker
According to the SEC Form 4 filings, Pratik S Multani has made a total of 1 transactions in Erasca Inc (ERAS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Erasca Inc is the acquisition of 6,200 shares on July 20, 2021, which cost Pratik S Multani around $99,200.
According to the SEC Form 4 filings, Pratik S Multani has made a total of 2 transactions in ORIC Pharmaceuticals Inc (ORIC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ORIC Pharmaceuticals Inc is the sale of 5,282 shares on December 15, 2023, which brought Pratik S Multani around $45,372.
Insider Trading History of Pratik S Multani
- 1
Pratik S Multani Trading Performance
GuruFocus tracks the stock performance after each of Pratik S Multani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pratik S Multani is 0.16%. GuruFocus also compares Pratik S Multani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pratik S Multani within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pratik S Multani's insider trading performs compared to the benchmark.
Performance of Pratik S Multani
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.05 | | | | | |
| Relative Return to S&P 500(%) | 6.31 | | | | | |
Pratik S Multani Ownership Network
Pratik S Multani Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Pratik S Multani is the director of Chimerix Inc. Other key executives at Chimerix Inc include Principal Accounting Officer David Jakeman , Chief Business Officer Michael T. Andriole , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Pratik S Multani made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net sale of 9,500 shares made by David Jakeman , and a net purchase of 87,000 shares made by Michael A. Sherman .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,184 shares of Chimerix Inc (CMRX) were sold and 173,750 shares were bought by its insiders, resulting in a net purchase of 160,566 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Pratik S Multani Mailing Address
Above is the net worth, insider trading, and ownership report for Pratik S Multani. You might contact Pratik S Multani via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
